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SUMMARY
RSV is the most important viral cause of pneumonia and bronchiolitis in children worldwide and
has been associated with signiﬁcant disease burden. With the renewed interest in RSV vaccines,
we provide realistic estimates on duration, and inﬂuencing factors on RSV shedding which are
required to better understand the impact of vaccination on the virus transmission dynamics. The
data arise from a prospective study of 47 households (493 individuals) in rural Kenya, followed
through a 6-month period of an RSV seasonal outbreak. Deep nasopharyngeal swabs were
collected twice each week from all household members, irrespective of symptoms, and tested for
RSV by multiplex PCR. The RSV G gene was sequenced. A total of 205 RSV infection episodes
were detected in 179 individuals from 40 different households. The infection data were interval
censored and assuming a random event time between observations, the average duration of virus
shedding was 11·2 (95% conﬁdence interval 10·1–12·3) days. The shedding durations were longer
than previous estimates (3·9–7·4 days) based on immunoﬂuorescence antigen detection or viral
culture, and were shown to be strongly associated with age, severity of infection, and revealed
potential interaction with other respiratory viruses. These ﬁndings are key to our understanding
of the spread of this important virus and are relevant in the design of control programmes.
Key words: Developing countries, Kenya, respiratory syncytial virus, shedding duration,
transmission dynamics.
INTRODUCTION
Respiratory syncytial virus (RSV) is a major viral
cause of lower respiratory tract infection in children
worldwide [1] with the key risk group being young
infants [2]. No vaccine is currently available for this
age group. Development of alternative control
strategies depends on the mechanisms of transmission,
which are intrinsically related to viral shedding [3, 4].
Detailed data on shedding in individuals in relation
to age, infecting subtype (groups A or B), infection
severity, and gender would help in identifying the
source of infant infection. Such data from the natural
setting unaffected by sampling bias are limited and ab-
sent in resource-poor settings. Additionally, this study
assesses the impact of the presence of other respiratory
viruses, prior to or concomitant with RSV, on RSV
infection duration. Any interaction might be mediated
through direct interference or host immune and
* Author for correspondence: Dr P. K. Munywoki, KEMRI –
Wellcome Trust Research Programme, Centre for Geographic
Medicine Research –Coast, Hospital Road, P.O. Box 230-80108,
Kiliﬁ, Kenya.
(Email: pmunywoki@kemri-wellcome.org)
Epidemiol. Infect. (2015), 143, 804–812. © Cambridge University Press 2014
doi:10.1017/S0950268814001393
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons
Attribution licence http://creativecommons.org/licenses/by/3.0/
physiological responses. These possibilities have
received very little attention in the literature.
Previous studies on RSV shedding have been
mainly in the hospital setting limiting the generaliz-
ability of the results [3, 5, 6]. Hospital studies are
biased to young children with severe RSV disease
and fail to precisely establish the start and, often,
the end of shedding, particularly when symptoms do
not coincide with virus shedding which is common
for RSV [6]. Community-based studies are likely to
provide a more complete representation of the RSV
shedding patterns. Such studies require frequent naso-
pharyngeal swabbing regardless of symptoms and use
of sensitive molecular techniques for viral testing in
order to minimize the likelihood of missing infection
episodes especially in older age groups.
The current prospective study utilizes the above
approach, with intensive sampling (every 3–4 days),
molecular testing, and follow-up of individuals of all
ages for one complete RSV season in a rural Kenyan
community [7]. This provides for more realistic esti-
mates on duration of and inﬂuencing factors on RSV
shedding which are required in designing RSV preven-
tion strategies and to better understand the impact of
vaccination on RSV transmission dynamics.
MATERIALS AND METHODS
The studywasundertaken in rural coastalKenyawithin
theKiliﬁHealth andDemographic Surveillance System
(KHDSS) [8]. The study methods have been described
elsewhere [7]. Brieﬂy, a prospective cohort study was
undertaken with a recruitment target of 50 RSV-naive
infants and their household members. A household
was deﬁned as a group of individuals living in the
same compound and with common cooking arrange-
ments. Households were eligible if they contained
a child born after the end of the 2008–2009 RSV
epidemic, and one or more older siblings (aged
<13 years). Sampling visits were timed to begin and
end coincident with the start and ﬁnish of the expected
RSV season of 2009–2010 [7]. Trained ﬁeld assistants
made twice weekly household visits, collecting deep
nasopharyngeal swabs (NPS) irrespective of symptoms
and recording clinical illness data from all participants.
Study procedures
NPS were collected and tested for RSV (groups A and
B) and other respiratory viruses [adenoviruses, rhino-
viruses and human coronaviruses (NL63, 229E,
OC43)] using real-time multiplex PCR as described
previously [7]. In order to establish the genetic simi-
larity of the RSV strains in suspected repeat infec-
tions, the ectodomains of the RSV attachment (G)
protein gene were sequenced and analysed phylogen-
etically [9].
Ethics
The authors assert that all procedures contributing
to this work comply with the ethical standards of
the relevant national and institutional committees
on human experimentation and with the Helsinki
Declaration of 1975, as revised in 2008.
Statistical analysis
Data were analysed using Stata version 11.2
(StataCorp, USA). The infection data were interval-
censored and three possible durations of viral shedding
were estimated, i.e.minimum,midpoint andmaximum,
as described in the Supplementary online material and
shown in Figure S1. An RSV infection episode was
deﬁned as the period within which an individual pro-
vided specimens which were PCR positive for the
same infecting RSV group with no more than 14 days
separating any two positive samples. Episodes where
the ﬁrst sample was positive for both RSV groups A
and B counted as one infection episode. Episodes
where no samples were collected for >7 days before
or after the infection episode were considered left- or
right-censored, respectively. Symptomatic infection
was deﬁned as the presence of one ormore of the follow-
ing symptoms: cough, nasal discharge/blocked nose, or
difﬁculty in breathing at any time during the infection
episode. Co-infection was assigned when within the
RSV episode any sample was PCR positive for
another virus, i.e. coronavirus, rhinovirus, or adeno-
virus. Presence of these viruses in the samples collected
in the period of 14 days prior to start of RSV episodes
was also deﬁned. Household outbreak was deﬁned
as a period within which more than one individual
episodes occurred in members of the same household
without an interval of 514 days in which a PCR-
positive specimen was absent from the household. The
proportion of the household members infected during
household outbreaks measured the intensity of the
outbreak.
Cox proportional hazards models were used to
identify factors inﬂuencing the rate of loss of virus
detection (hereafter referred as the recovery rate).
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The effect of left-censoring was accounted for in the
multivariate model by including a dummy variable
or by excluding the left-censored episodes.
RESULTS
Baseline characteristics of RSV-infected individuals
Of the 493 individuals in the 47 households followed,
179 (36·3%) had at least one RSV infection from 40
(85·1%) different households. The median age (inter-
quartile range; IQR) at the start of the ﬁrst observed
infection was 6·5 (IQR 2·4–14·5) years, and females
numbered 96 (53·6%) (Table 1).
RSV infection episodes
A total of 205 infection episodes were observed with
155 individuals experiencing one episode, 22 with two
episodes and two individuals experiencing three epi-
sodes (Fig. 1). RSV group Awas associated with 88 in-
fection episodes, RSV group B with 113 while seven
episodes were co-infections. There were 177 (86·3%)
fully observed episodes while 11 and 15 infection epi-
sodes were left- and right-censored, respectively, and
two episodes were both left- and right-censored. Of
the 24 individuals with two ormore episodes (suspected
repeat infections), 17 (70·8%) were infected with the
same RSV group and otherwise all except one group
A infection followed group B. The mean age at the
Table 1. Baseline characteristics of the 179 study participants and the associated RSV infection episodes
Covariates Categories
Personsa (N=493) Episodesb (N=205)
n % n %
Age in years, at start of sampling
<1 yr 55 11·2 37 18·1
1–<5 yr 82 16·6 49 23·9
5–<15 yr 165 33·5 74 36·1
15–<40 yr 147 29·8 36 17·6
540 yr 44 8·9 9 4·4
Relationsc Study infant 47 9·5 34 16·6
Sibling 164 33·3 79 38·5
Cousin 124 25·2 55 26·8
Mother 46 9·3 14 6·8
Father 33 6·7 6 2·9
Other 79 16·0 17 8·3
Gender Female 272 55·2 116 56·6
Male 221 44·8 89 43·4
RSV subtype Group A — — 81 39·5
Group B — — 110 53·7
Groups A and B — — 14 6·8
Order of infection First — — 179 87·3
Second — — 26 12·7
Symptomatic, i.e. with ARI No — — 87 42·4
Yes — — 118 57·6
Presence of co-infection No — — 119 58·1
Yes — — 86 42·0
During household outbreak No — — 42 20·5
Yes — — 163 79·5
Outcome
Durationd <7 days — — 74 36·1
7–<14 days — — 75 36·6
15–<21 days — — 32 15·6
521 days — — 24 11·7
RSV, Respiratory syncytial virus; ARI, acute respiratory illness.
a Number of individuals in the parent study.
b RSV infection episodes.
c The relationship of household members with the study infant.
d Duration of RSV shedding episodes.
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ﬁrst infection for individuals with RSV group A and
group B was 2·3 and 7·2 years, respectively. The dur-
ation between the episodes ranged from 17 to 54 days
with median of 28 days. For the 17 homologous infec-
tions, sequencing of the RSV G gene was successful
in 10 (59%) of the 18 possible pairs of samples (one
individual had three suspected RSV episodes). The
failure to sequence was mainly in samples with a
PCR cycle threshold (Ct) value of >28·0, an indicator
of low viral load. Only one of the successfully
sequenced paired samples showed nucleotide differ-
ences: 13 nucleotide differences associated with three
non-synonymous changes and a change in the stop
codon position. The episodes in this individual (ID
no. 1803 in Fig. 2) occurred 54 days apart. For the
purposes of estimation of the shedding duration, all
the episodes were considered distinct.
Duration of RSV shedding
From the 205 infection episodes, the mean duration
of shedding based on minimum, midpoint and maxi-
mum estimates were 8·6 [95% conﬁdence interval
(CI) 7·5–9·7], 11·2 (95% CI 10·1–12·3) and 14·0
(95% CI 12·8–15·2) days, respectively, for all RSV epi-
sodes (Fig. 3). The corresponding mean durations
of shedding for the ‘fully observed’ episodes were 8·2
(95% CI 7·1–9·4), 10·9 (95% CI 9·8–12·1) and 13·6
(95% CI 12·4–14·8) days, respectively (Table 2).
Twenty-four individuals shed RSV for 521 days,
and of these 10 (41·7%) were aged <1 year, six
(25·0%) were aged 1–4 years, and eight (29·2%) aged
5–17 years. Twenty-two (91·7%) of these infection
episodes were symptomatic throughout or at some
time point during the shedding. The prolonged
shedders contributed 647·5 days of RSV shedding
which was 29·7% of the cumulative shedding duration
for all episodes based on the midpoint estimation.
In 14 infected individuals, one or more samples were
identiﬁed to contain both RSV groups A and B. The
timing of these co-detections is shown in Figure 4. In
most (12/14) episodes, RSV group A was shed for
longer duration relative to group B.
Factors inﬂuencing the rates of recovery from RSV
infection
The hazard ratios (HRs) for the various factors
from univariate Cox regression were similar for mini-
mum, midpoint and maximum estimates data
(Supplementary Table S1). The midpoint data were
taken forward for the multivariate analysis and the
ﬁnal model is reported in Table 3. The results were
similar without and with inclusion of the left-censored
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Fig. 1. Respiratory syncytial virus (RSV) group A (a) and group B (b) episodes ordered by age at infection. RSV-positive
samples are marked by a blue ‘× ’ while the red line links PCR-positive samples from the same infection episode.
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RSV episodes (Table 3 and Supplementary Table S2,
respectively). The proportionality assumption in the
Cox regression model was not violated based on the
test of the Schoenfeld residuals (Supplementary
Table S3).
The rate of recovery from RSV infection was
age-dependent. The adjusted HR (aHR) were 1·98
(95% 1·30–3·02), 1·82 (95% CI 1·16–2·87), 2·10
(95% CI 1·20–3·66) and 1·31 (95% CI 0·36–4·81) in
the 1–4, 5–14, 15–39 and 540 years age groups,
respectively, relative to infants (<1 year). The rate of
recovery was lower by 44% in symptomatic infections
relative to asymptomatic infections (aHR 0·56, 95%
CI 0·40–0·79). The presence of one or more additional
viruses (rhinovirus, coronavirus, adenovirus) was
detected in 86 RSV infection episodes. The rate of
RSV recovery was lower (i.e. shedding duration
increased) by 65% in episodes with co-infection
compared to those without (aHR 0·35, 95% CI
0·23–0·51), with a similar result for each virus
individually. Detection of infection with any one or
more of rhinovirus, adenovirus or coronavirus, in
the 2 weeks preceding the start of RSV infection,
but not during the RSV episode itself, was associated
with a 56% increase in the rate of recovery (i.e.
reduced shedding duration) from the RSV infection
(aHR 1·56, 95% CI 1·02–2·39). In contrast, RSV epi-
sodes associated with detection of other viruses in
the 2 weeks prior to and also during the RSV infection
were associated with a 52% decrease in the rate of
recovery relative to those with no other virus prior
to and during the RSV episode (aHR 0·48, 95%
CI 0·32–0·73). The rate of recovery of RSV episodes
associated with spread in the household (outbreaks)
was 42% lower than the single household episodes
(aHR 0·58, 95% CI 0·43–0·78). A variable denoting
the proportion of individuals infected during the
household outbreak improved the model ﬁt and was
used in the multivariate analyses (likelihood ratio
test P=0·0229).
The rate of recovery did not differ signiﬁcantly by
gender and infecting RSV group (aHR 0·97, 95% CI
0·77–1·23 and aHR 1·07, 95% CI 0·83–1·39, respect-
ively). Recovery rate was similar in suspected repeat
infections compared to the ﬁrst observed episodes
(aHR 0·91, 95% CI 0·53–1·56).
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Fig. 2. Infection episodes for 17 individuals with suspected repeat infection with the same respiratory syncytial virus
(RSV) group showing RSV G gene variability. Green solid circles indicate samples were collected but RSV negative; red
crosses (×) indicate RSV-positive samples but not sequenced; solid red or blue circles show RSV-positive samples
successfully sequenced. If red is in both episodes then the variants in each episode were identical and if one episode is red
and the other blue then they were non-identical. Open pink diamonds (◇) represent detection of other viruses; open black
circles (○) show when the individual had respiratory symptoms. Age (in years) at the start of the ﬁrst episode is in blue,
with the corresponding interval between episodes (in days) in grey. ID, Unique identiﬁer of the individual.
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DISCUSSION
We observed 205 infections with RSV during one
epidemic with a most realistic estimate of 11·2 (95%
CI 10·1–12·3) days of shedding. The most conserva-
tive and least conservative estimates were 8·6 days
and 14·0 days, respectively. The duration of shedding
based on the most realistic estimate decreased with
age: 18 days in infants and 9 days in adults (aged
515 years). Symptomatic infections on average had
longer virus shedding of 13·5 days compared to
7·8 days in asymptomatic episodes. The presented
average durations of virus shedding are longer than
published estimates of 6·7 days [4], 3·4–7·4 days [10],
3·9 days [11], and 4·5 days [12] which could be attrib-
uted to differences in study methods. The present
study was informed by critical review of the previous
studies and it incorporated frequent sampling regard-
less of symptoms and screening by highly sensitive
PCR methods. The specimen collection procedure
was acceptable, recording a good compliance across
all ages [7, 13]. The use of the sensitive viral detection
method (PCR) results is likely to result in longer esti-
mates of shedding.
A community study nested within a birth cohort in
coastal Kenya targeting symptomatic RSV infections
by Okiro and colleagues reported a mean duration
of shedding of 4·5 days [12]. Our corresponding esti-
mate in symptomatic cases was 13·5 days. In a subset
of the children whose start of symptoms could be
established from the clinic records, the Okiro et al.
study reported a longer duration of 7·7 days [12].
Given that RSV shedding has been reported to start be-
fore illness [6], the actual duration in the symptomatic
children would have been an underestimate and our
estimate of 13·5 days is likely to be more accurate.
A Rochester family study, in the USA, with similar
design as the present study (collecting samples every
3–4 days regardless of symptoms) reported lower esti-
mates of duration of shedding of 3·4–7·4 days [10].
The Okiro et al. and Rochester study used the immu-
noﬂuorescent antibody test (IFAT) and culture, re-
spectively, which are less sensitive methods [14]. As a
counter argument, it is not known to what degree
PCR positivity equates with shedding of viable and in-
fectious virus. Thus, while the molecular methods
might be more sensitive, the resultant increase in dur-
ation of shedding over more traditional methods such
as culture (which directly measures viral infectivity)
may not necessarily translate to increased period of
infectivity. Further work relating virus infectiousness
and detectability is warranted. In the Okiro et al.
study, sampling started when participants were symp-
tomatic and stopped at the ﬁrst negative follow-up
sample. The present study revealed instances where
negative samples arose within RSV infection episodes.
Even though this observation raises, again, questions
on the relationship between infectivity and shedding
duration, accounting for periods of RSV-negative sam-
ples would still result to longer shedding duration com-
pared to previous estimates. Alternative estimation of
the shedding patterns by calculating the area under
the Ct (viral load) curve would have some additional
advantages and will be explored in future.
Prolonged shedders of > 3 weeks’ duration have
been reported [6, 10]. In the present study, 24
(13·4%) episodes in the 179 infected individuals
involved shedding RSV for >3 weeks. Most
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Fig. 3. Kaplan–Meier plots showing the (a) minimum,
(b) midpoint and (c) maximum estimates of median
duration of respiratory syncytial virus shedding. IQR,
Interquartile range.
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(22, 91·7%) of these episodes were symptomatic, and
occurred in young children (median age 14·7 months).
Individuals with compromised immunity have been
known to shed RSV for longer [15] but participants
in the current study were not tested for HIV.
The HIV prevalence in women and men aged
15–49 years in coastal Kenya was 4·2% according to
the Kenyan Demographic and Health Survey of
2008/2009 [16]. In settings where HIV prevalence is
high, the effect of the poor viral clearance might inﬂu-
ence the temporal epidemiology as was observed in
South Africa [15]. There was no obvious malnour-
ished participant in the study cohort based on mid-
upper arm circumference measurements.
More than two RSV episodes were observed in
24 (13·4%) individuals. On average, the episodes
were 4 weeks apart. Most (70·8%) of the suspected re-
peat infections were with homologous RSV group.
Sequencing of the most variable region of the RSV
genome, the ectodomain of the G gene, did not greatly
assist in resolving the infection episodes as most (9/10)
had identical sequences. It is, thus, not clear whether
the two phases of RSV shedding were repeat infections
with the same variant or were persistent infection with
periods of low viral load that was undetectable by the
methods used. Using post-mortem lung tissue from
infants, RSV RNA has been detected even in children
dying during inter-epidemic periods suggesting the
persistence of RSV in the lungs of these infants [17].
Similar observations have been made in experimental
infection with RSV [18] and measles viruses [19]. The
lack of variability in the virus identiﬁed in the two
phases of infections suggests virus mutation might
not be the primary mechanism for virus persistence
or re-infection. Regardless of whether it is re-infection
within a short period or persistence, the observation
represents an interesting phenomenon of RSV which
has potential importance on our existing view of
acute RSV infection, the development of immunity
and effects on viral transmission.
The age of the individual, infection severity, detec-
tion of other viruses before and during the RSV infec-
tion, and presence of concurrent RSV infections in
the same household were all associated with virus
shedding.The rate of recovery increasedwith increasing
age, with individuals in 1–4 years, 5–15 years and
515 years age groups recovering 1·98, 1·82 and 1·97
times faster than the infants, respectively. The
Rochester family study reported similar ﬁndings
where longer shedding was observed for children
aged <2 years compared to those aged 2–16 years
14
12
10
8
In
div
idu
als
6
4
2
1
0 10 20
Duration in days
30 40
Fig. 4. Respiratory syncytial virus (RSV) shedding in
episodes associated with co-detection of RSV groups A
and B. The solid red circle (●) and blue marker (×)
represents RSV groups A and B, respectively. The red line
links PCR-positive samples denoting the RSV episode.
Table 2. Sampling intervals, age at infection and estimated shedding duration by the censoring type
Characteristic Alla (n=205) Fullyb (n=177) Leftc (n=11) Rightd (n=15) Bothe (n=2)
Sampling intervalsf Mean 95% CI Mean 95% CI Mean 95% CI Mean 95% CI Mean 95% CI
Before 4·2 3·8–4·5 3·7 3·6–3·9 9·6 8·6–10·5 3·4 2·8–4·0 18·50 —
During 3·5 3·4–3·6 3·5 3·4–3·6 3·8 2·8–4·9 4·1 3·1–5·0 — —
After 5·2 4·2–6·3 3·7 3·5–3·8 3·4 2·4–4·3 24·1 13·3–34·9 11·0 —
Age, yearsg 11·1 9·3–13·0 10·4 8·6–12·3 15·1 5·0–25·1 15·6 6·5–24·6 16·9 —
Shedding durationh 10·6 9·6–11·7 10·9 9·7–12·1 7·4 4·5–10·2 8·9 6·7–11·0 14·8 —
CI, Conﬁdence interval; RSV, respiratory syncytial virus.
a All RSV infection episodes; b fully observed episodes; c left-censored episodes only; d right-censored episodes only; e episodes
with both left and right censoring; f intervals between nasopharyngeal swab collection before, during, and after the RSV in-
fection episode in days; g age (in years) at the start of the episode; h shedding duration (in days) based on the midpoint
estimation.
810 P. K. Munywoki and others
(9 vs. 4 days). The Okiro et al. study did not ﬁnd any as-
sociationwith age but found that childrenwith previous
RSV infection (using the assumption that those aged
>3yearswerebydefault experiencing a repeat infection)
had 1·37 times faster rate of recovery compared to those
without ahistoryof infection [12]. In the present study, a
subsequent RSV infection during the same RSV season
was not signiﬁcantly associated with reduced shedding
duration, but such infections were few (n=24). The
current study is for one epidemic only, so age must
act as a proxy of exposure to RSV in earlier epidemics.
Prolonged shedding enhances the possibility of person-
to-person transmission and makes young children a
potential source of community spread of infection,
both of which have important implications in the con-
trol and prevention of RSV infection.
A study involving 23 hospitalized children (aged
<2 years) with sampling extended beyond discharge
reported an association of duration of shedding and
symptom severity [4]. Children with lower respiratory
tract infection shed for longer than those with upper
respiratory tract infection (8·4 vs. 1·4 days). Duration
of shedding may be related to severity of disease but
evidence is controversial on the link between disease
severity and viral load [5, 20–22].
An interaction between detection of other viruses
(i.e. coronavirus, rhinovirus, adenovirus) in the naso-
pharynx and rate of recovery from RSV infection was
observed. Recovery from a viral infection just prior
to RSV might have led to up-regulation of innate viral
immunity or non-speciﬁc cross-reactivity that reduced
subsequent RSV shedding. Presence of co-infections
might be a marker of low immunity associated with
poor viral clearance. RSV episodes with concurrent
spread in the household were associated with increased
recovery rate. However, any conclusions other than
association cannot bemade since the extended duration
of shedding increases the risk of both co-infection with
other viruses and multiple RSV infections in the house-
hold. A different estimation framework is required to
untangle these results.
The problems of ascertainment and analysis (i.e.
censoring and test sensitivity) are not completely
eliminated by the careful study design, but did not
seem to affect the association of the examined factors
with virus shedding (Supplementary Table S1). Short
RSV infections occurring between specimen collec-
tions particularly in older individuals might have
been missed but this is likely to be at random and
bias hazard ratios towards null.
In conclusion, this study deﬁnes RSV shedding pat-
terns in the natural setting with signiﬁcant potential
for improved understanding of the spread of this im-
portant virus and with relevance the design of control
programmes.
SUPPLEMENTARY MATERIAL
For supplementary material accompanying this paper
visit http://dx.doi.org/10.1017/S0950268814001393.
Table 3. Final multivariate Cox regression modela: factors inﬂuencing the rates of recovery from RSV infection in
rural Kenya
Factors Categories Reference HR 95% CI P value
Age group, years
1–4 yr <1 year 1·98 1·30–3·02 0·002
5–14 yr 1·82 1·16–2·87 0·01
515 yr 1·97 1·11–3·51 0·021
Symptomatic Asymptomatic 0·56 0·40–0·79 0·001
Detection of otherb viruses before and
during RSV episode
Beforec No other viruses 1·56 1·02–2·39 0·041
During 0·48 0·32–0·73 <0·001
Other household members infected (%) 533%–66% <33% 0·59 0·40–0·87 0·008
>66% 0·51 0·35–0·74 <0·001
RSV group B A 1·07 0·83–1·39 0·588
Male gender Female 0·97 0·77–1·23 0·804
Second RSV episode First 0·91 0·53–1·56 0·73
RSV, Respiratory syncytial virus; HR, hazard ratio; CI, conﬁdence interval.
a Left-censored episodes excluded.
b Other viruses were adenoviruses, rhinoviruses and coronaviruses.
c Detection of other respiratory viruses during the 14 days prior to the start of RSV episode only.
Shedding patterns of RSV in rural Kenya 811
ACKNOWLEDGEMENTS
We thank the ﬁeld and laboratory teams for their
dedication in sample collection and testing, respect-
ively. The article is published with the permission
of the Director of the Kenya Medical Research
Institute. This work was supported by the Wellcome
Trust (090853 and 084633).
DECLARATION OF INTEREST
None.
REFERENCES
1. Nair H, et al. Global burden of acute lower respiratory
infections due to respiratory syncytial virus in young
children: a systematic review and meta-analysis. Lancet
2010; 375: 1545–1555.
2. Glezen WP, et al. Risk of primary infection and reinfec-
tion with respiratory syncytial virus. American Journal
of Diseases of Children 1986; 140: 543–546.
3. Waris M, et al. Shedding of infectious virus and virus
antigen during acute infection with respiratory syncytial
virus. Journal of Medical Virology 1992; 38: 111–116.
4. Hall CB, Douglas Jr. RG, Geiman JM. Respiratory syn-
cytial virus infections in infants: quantitation and dur-
ation of shedding. Journal of Pediatrics 1976; 89: 11–15.
5. Hall CB, Douglas Jr. RG, Geiman JM. Quantitative
shedding patterns of respiratory syncytial virus in
infants. Journal of Infectious Diseases 1975; 132: 151–
156.
6. Frank AL, et al. Patterns of shedding of myxoviruses
and paramyxoviruses in children. Journal of Infectious
Diseases 1981; 144: 433–441.
7. Munywoki PK, et al. The source of respiratory syncytial
virus infection in infants: a household cohort study in
rural Kenya. Journal of Infectious Diseases. Published
online: 25 December 2013. doi: 10.1093/infdis/jit828.
8. Scott JA, et al. Proﬁle: The Kiliﬁ Health and Demo-
graphic Surveillance System (KHDSS). International
Journal of Epidemiology 2012; 41: 650–657.
9. Agoti CN, et al. Genetic relatedness of infecting and
reinfecting respiratory syncytial virus strains identiﬁed
in a birth cohort from rural kenya. Journal of Infectious
Diseases 2012; 206: 1532–1541.
10. Hall CB, et al. Respiratory syncytial virus infections
within families. New England Journal Medicine 1976;
294: 414–419.
11. Hall CB, Long CE, Schnabel KC. Respiratory syncytial
virus infections in previously healthy working adults.
Clinical Infectious Diseases 2001; 33: 792–796.
12. Okiro EA, et al. Duration of shedding of respiratory
syncytial virus in a community study of Kenyan chil-
dren. BMC Infectious Diseases 2010; 10: 15.
13. Munywoki PK, et al. Improved detection of respiratory
viruses in pediatric outpatients with acute respiratory
illness by real-time PCR using nasopharyngeal ﬂocked
swabs. Journal of Clinical Microbiology 2011; 49:
3365–3367.
14. Reis AD, et al. Comparison of direct immunoﬂuores-
cence, conventional cell culture and polymerase chain
reaction techniques for detecting respiratory syncytial
virus in nasopharyngeal aspirates from infants. Journal
of the São Paulo Institute of Tropical Medicine 2008;
50: 37–40.
15. Madhi SA, et al. Increased burden of respiratory viral
associated severe lower respiratory tract infections in
children infected with human immunodeﬁciency virus
type-1. Journal of Pediatrics 2000; 137: 78–84.
16. Kenya National Bureau of Statistics (KNBS) and ICF
Macro. Kenya Demograpghic and Health Survey
2008–09. Calverton, Maryland, USA: KNBS and ICF
Macro, 2010.
17. Cubie HA, et al. Detection of respiratory syncytial virus
nucleic acid in archival postmortem tissue from infants.
Pediatric Pathology and Laboratory Medicine 1997; 17:
927–938.
18. Schwarze J, et al. Latency and persistence of respiratory
syncytial virus despite T cell immunity. American Jour-
nal of Respiratory Critical Care Medicine 2004; 169:
801–805.
19. Lin WH, et al. Prolonged persistence of measles virus
RNA is characteristic of primary infection dynamics.
Proceedings of the National Academy of Sciences USA
2012; 109: 14989–14994.
20. DeVincenzo JP, El Saleeby CM, Bush AJ. Respiratory
syncytial virus load predicts disease severity in pre-
viously healthy infants. Journal of Infectious Diseases
2005; 191: 1861–1868.
21. Kuypers J, Wright N, Morrow R. Evaluation of quanti-
tative and type-speciﬁc real-time RT-PCR assays for de-
tection of respiratory syncytial virus in respiratory
specimens from children. Journal of Clinical Virology
2004; 31: 123–129.
22. Devincenzo JP. Natural infection of infants with respir-
atory syncytial virus subgroups A and B: a study of
frequency, disease severity, and viral load. Pediatric
Research 2004; 56: 914–917.
812 P. K. Munywoki and others
